| Identification | |
| Name: | Erlotinib |
| Synonyms: | Erlotinib base;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,;N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; |
| CAS: | 183321-74-6 |
| Molecular Formula: | C22H23N3O4 |
| Molecular Weight: | 393.43572 |
| InChI: | InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.24 |
| Water Solubility: | very slightly soluble (slightly soluble in methanol, insoluble in acetonitrile, acetone, ethyl acetate, hexane) |
| Solubility: | very slightly soluble (slightly soluble in methanol, insoluble in acetonitrile, acetone, ethyl acetate, hexane) |
| Appearance: | white to off-white powder |
| Specification: |
?Erlotinib , its cas register number 183321-74-6. It also can be called?Tarceva ; UNII-J4T82NDH7E ;?N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine ; and 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline .?Its classification code are Enzyme Inhibitors and Protein Kinase Inhibitors. |
| Safety Data | |
 |
|
